Dr. Rahul Kushwah reports

PREDICTMEDIX AI LAUNCHES NEXT-GENERATION CLINICAL-TRIAL AI PLATFORM

Predictmedix AI Inc. has launched its clinical trial artificial intelligence platform, an artificial-intelligence-driven solution intended to help pharmaceutical sponsors and contract research organizations model, plan and adapt clinical trials more efficiently.

A digital brain for clinical trials

Built on patented technology and the high-fidelity data set generated by SmartHealth AI stations, the platform is designed to function as a real-time digital support system for trial planning. It ingests and harmonizes diverse data sets -- patients, protocols, sites, historical outcomes and costs -- and can update analyses as new data become available.

Key features:

1. Adaptive simulation engine -- runs what-if scenarios and refreshes projections as enrolment and site performance information is received;
2. Patient-site optimization -- uses AI to recommend patient-site matching that may improve recruitment and reduce dropouts;
3. Cost and return on investment modelling -- proprietary algorithms estimate potential budget impact alongside predicted clinical outcomes;
4. Interactive dashboards -- executive and audit views visualize risk, cost and patient flow with dynamic heat maps and Sankey plots;
5. Compliance-integrated AI -- tracks data inputs and simulations to support audit and regulatory processes.

Market context

Industry analysts estimate the global clinical trial market could exceed $70-billion by 2027, creating demand for tools that help sponsors reduce trial failures, improve patient recruitment and manage costs. Predictmedix's platform is intended to address these needs with scalable, real-time analytics.

"Clinical development urgently needs smarter tools," said Dr. Rahul Kushwah, chief operating officer of Predictmedix. "Our platform is designed to highlight potential clinical trial challenges early, enabling sponsors to make informed adjustments that can help save time and resources and, ultimately, support faster delivery of new therapies."

Distinctive capabilities

The platform is built around real-time adaptive AI, with automation applied across data ingestion, simulation and outcome modelling:

1. Continuous intelligence: Projections adjust as enrolment numbers, site performance or protocol variables change.
2. End-to-end automation: From raw data to executive dashboards, workflows are automated to reduce manual reconciliation.
3. Multitrial orchestration: A single environment can simulate multiple protocols and allocate resources across a development portfolio.
4. Cost outcome integration: Financial modelling is embedded directly into clinical predictions for unified decision support.
5. Validated data streams: The system draws on more than 500,000 SmartHealth scans, which internal and third party assessments have measured at approximately 95-per-cent accuracy for vital sign detection. Actual results may vary.

Predictmedix is preparing to provide private demonstrations and explore paid pilot programs with pharmaceutical sponsors and contract research organizations as opportunities emerge.

About Predictmedix AI Inc.

Predictmedix is an emerging provider of rapid health screening and remote patient care solutions globally. The company's SmartHealth AI stations -- powered by proprietary artificial intelligence -- use multispectral cameras to analyze physiological data patterns and predict a variety of health issues including 19 physiological vital signs, impairment by drugs or alcohol, fatigue, or various mental illnesses. Predictmedix AI's proprietary remote patient care platform empowers medical professionals with a suite of artificial-intelligence-powered tools to improve patient health outcomes.

We seek Safe Harbor.